Skip to main content
AVACTA GROUP PLC logo

AVACTA GROUP PLC — Investor Relations & Filings

Ticker · AVCT ISIN · GB00BYYW9G87 LEI · 2138009U3EG31OPMGH36 IL Manufacturing
Open in API
Filings indexed 708 across all filing types
Latest filing 2023-09-20 Declaration of Voting R…
Country GB United Kingdom
Listing IL AVCT

About AVACTA GROUP PLC

https://avacta.com/

Avacta Group PLC is a clinical-stage biotechnology company developing targeted oncology drugs. The company's core technology is the proprietary pre|CISION® platform, a drug delivery system designed to improve the safety and efficacy of potent cancer therapies. The platform works by linking a peptide to a cancer drug, rendering it inactive in the bloodstream. The drug is precisely activated only within the tumor microenvironment by the Fibroblast Activation Protein (FAP) enzyme, which is abundant in many solid tumors. This approach aims to concentrate the active therapy at the tumor site, thereby reducing systemic toxicity and improving the therapeutic window for patients. The company is advancing a pipeline of peptide drug conjugates (PDCs) based on this platform.

Recent filings

Filing Released Lang Actions
Issue of Equity and Total Voting Rights
Declaration of Voting Results & Voting Rights Announcements Classification · 100% confidence The document is identified by the header 'RNS Number : 1042N' and contains information about the 'Issue of Equity and Total Voting Rights' resulting from a convertible bond conversion. This announcement details the issuance of 715,789 new ordinary shares and the resulting total voting rights (280,082,440). This type of corporate action, specifically related to changes in the number of shares outstanding, falls under the category of Share Issue/Capital Change (SHA). Although it is distributed via RNS, the specific content is about a capital change, making SHA the most precise classification over the general RNS fallback.
2023-09-20 English
Peel Hunt Appointed as Joint Broker
Capital/Financing Update Classification · 99% confidence The document begins with 'RNS Number : 9859M' and is dated '20 September 2023'. It contains standard boilerplate language associated with regulatory news services, specifically mentioning 'RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom.' The content itself is a brief announcement regarding the appointment of Peel Hunt as Joint Broker. This type of short, immediate corporate update that is distributed via the official regulatory news service (RNS) fits best under the general 'Regulatory Filings' category, as it is not a specific financial report (like 10-K or IR), a management change (MANG), or a dividend announcement (DIV). Given the source and nature, RNS is the most appropriate classification.
2023-09-20 English
Appointment Dr.Christina Coughlin as a consultant
Regulatory Filings Classification · 98% confidence The document is identified by the 'RNS Number : 9856M' and contains a date stamp ('20 September 2023') typical of regulatory news service announcements. The content details the 'Appointment of Dr. Christina Coughlin as a consultant' and explicitly labels this as a 'Related party transaction notification' according to AIM rules. This type of announcement, concerning changes in senior personnel (even temporary consultancy roles that trigger related party rules) and executive movements (departure of Neil Bell), falls under the category of Board/Management Information (MANG). While it is distributed via RNS, the specific subject matter is management change, making MANG the most precise classification over the general RNS fallback.
2023-09-20 English
Successful Completion of Sixth Dose Escalation
Regulatory Filings Classification · 98% confidence The document begins with an 'RNS Number' and is dated September 19, 2023. It contains a headline announcing 'Successful Completion of ALS-6000-101 Sixth Dose Escalation and Clinical Update' regarding a drug trial (AVA6000). The text explicitly mentions that the announcement contains inside information for MAR purposes and is being published via a 'Regulatory Information Service' (RNS). The structure, the RNS header, and the nature of the content (a timely operational/clinical update) strongly indicate this is a regulatory news service release. Since it is a general operational update that doesn't fit the specific categories like ER (Earnings Release), DIV (Dividend), or DIRS (Director's Dealing), the most appropriate classification is the general regulatory announcement fallback category, RNS.
2023-09-19 English
Notice of Results
Report Publication Announcement Classification · 99% confidence The document is an official announcement filed via RNS (RNS Number : 4814L) from Avacta Group PLC. The title is "Notice of Results" and the content explicitly states that the company "will announce its unaudited interim results for the six months ended 30 June 2023 on Thursday 28 September 2023." It further announces an investor presentation related to these results. Since the document is an announcement about the future publication of results and an associated presentation, and it is not the full report itself, it fits the definition of a Report Publication Announcement (RPA). It is not the Interim Report (IR) itself, nor is it the Earnings Release (ER) which typically contains the actual results figures. The document is short and serves to inform stakeholders about the upcoming release event.
2023-09-06 English
Issue of Equity and Total Voting Rights
Share Issue/Capital Change Classification · 99% confidence The document begins with 'RNS Number : 8454G' and is dated '21 July 2023'. The content details the 'Issue of Equity and Total Voting Rights' resulting from the conversion of an unsecured convertible bond, leading to the allotment of new ordinary shares and an update on the total voting rights. This type of announcement, which reports on changes in share capital, insider transactions, or significant corporate actions via the Regulatory News Service (RNS) system, fits best under the Share Issue/Capital Change (SHA) category, as the primary focus is the issuance of new shares and the resulting capital structure change. While it is distributed via RNS, SHA is more specific than the general RNS fallback.
2023-07-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.